LivaNova is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Vladimir A. Makatsaria, with a market cap of $3.5B.
Common questions about LivaNova
LivaNova is scheduled to report earnings for Q1 2026 on May 6, 2026 before market open. Analysts estimate revenue of $346.1M.
LivaNova has approximately 2,900 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.